MAGEA1 and hematopoietic and lymphoid cell neoplasm: Data from all (n = 10) investigated hematological cancer cells showed significant (p < 0.05) differences in levels of NY-ESO-1 and MAGE-A1 expression after treatment with all DHAs, compared to untreated cells (Supplementary Tables 6, 8).